comprehensive -WSS

comprehensive

author：entertainment 2025-09-04 21:59:05 - browse：39

Steven Pearson — ICER President Steven D. Pearson Craig F. Walker/The Boston Globe

Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. But a meeting Thursday at the Massachusetts Institute of Technology may prove to be the exception to that rule.

Patients Rising Now, an advocacy group that says it promotes transparency in health care and that is a fierce opponent of ICER’s, is expected to face off with the self-professed “watchdog of drug pricing” as it reviews three drugs for Duchenne muscular dystrophy.

Dozens of Duchenne patients and their families — many of whom also express concern that ICER’s review could undermine insurers’ already tepid interest in the treatments — are also expected to be in attendance.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

focus

WSS

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Reporting on presidential health from Reagan to Trump and Biden

MD Anderson's Padmanee Sharma responds to research credit suit

Illinois to ban advertising for guns allegedly marketed to kids and militants

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

focus

comprehensive

focus

Continuity nursing helped my family in our darkest PICU moments

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

ChatGPT in medicine: STAT answers readers' burning questions

NYC plans to house migrants on an island in the East River

Bright Health sells Medicare Advantage business to Molina

'The Exorcist' director William Friedkin dead at 87

The high cost of giving birth even with insurance

Medicare Advantage enrollment hits roughly 33.4 million

Psychedelics group wrestles with new pharma identity

Moderna hits safety problems in bold bid to reinvent medicine

focus

3 dead in firefighting helicopter crash in California after midair collision with 2nd helicopter

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

MD Anderson's Padmanee Sharma responds to research credit suit

Nearly a dozen Russian and Chinese ships now moving away from Alaska, officials say

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Abridge raises $150m as clinical notes automation market heats up

focus

leisure time

focus

knowledge